M&A activity among pharmaceutical and life sciences companies is expected to rebound in 2023 despite economic headwinds. Sector Outlook The global pharmaceutical sector experienced unprecedented volatility during recent years. As...
Read More
Industry Outlook The outbreak of the COVID-19 pandemic had a positive effect on M&A activity in the global Healthcare sector. After an initial slowdown in 2020, 2021 saw record activity...
Read More
